Hematologic Diseases
Solid Tumors

When serial or subsequent COMPASS® evaluations are requested on the same patient and deemed clinically appropriate by a Genoptix Hematopathologist, Genoptix will automatically provide a CHART® report, unless otherwise indicated by the ordering physician. CHART® includes all medically necessary technologies, and a consultative review and correlation with relevant prior findings and intervening treatment by a Genoptix Hematopathologist.

disease state indication(s)
Various, case dependent

clinical use
Various, case dependent

methodology/product platform
Refer to individual tests and technologies

specimen type and requirements
Refer to individual tests for the most current specimen type and requirements

turnaround time
Global (TC & PC): 10 days

cpt code(s)
Refer to individual tests for CPT Code(s)

medicare moldx cpt code
Not applicable

regulatory classification
Refer to individual tests

ordering option
Global (TC & PC)